iHuman Inc. (IH)

iHuman Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	149.56	180.91	109.82	-37.05	-48.27	-276.42
Depreciation & Amortization	-	11.69	10.83	6.42	2.81	0.6
Share-Based Compensation	-	9.44	13.04	15.18	79.89	270.54
Other Operating Activities	-149.56	-29.91	54.77	53.67	166.97	46.27
Operating Cash Flow	-	172.12	188.47	38.21	222.99	42.63
Operating Cash Flow Growth	-	-8.67%	393.19%	-82.86%	423.11%	-
Capital Expenditures	-	-6.51	-6.51	-31.95	-15.91	-2.39
Change in Investments	-	0	-26.33	0	0	0
Investing Cash Flow	-	-6.51	-32.84	-31.95	-15.91	-2.39
Share Issuance / Repurchase	-	-9.54	-6.96	-0.16	629.55	123.44
Debt Issued / Paid	-	0	0	0	0	-61.82
Other Financing Activities	-	0.09	0	0.57	-57.6	-3.1
Financing Cash Flow	-	-9.45	-6.96	0.41	571.96	58.52
Exchange Rate Effect	-	7.6	45.97	-12.99	-22.24	0
Net Cash Flow	-	163.77	194.64	-6.32	756.8	98.76
Free Cash Flow	-	165.61	181.96	6.26	207.08	40.24
Free Cash Flow Growth	-	-8.98%	2805.27%	-96.98%	414.66%	-
Free Cash Flow Margin	-	16.27%	18.46%	0.66%	38.93%	18.40%
Free Cash Flow Per Share	-	3.14	3.41	0.12	4.58	1.11

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).